A Day Up For Applied Therapeutics, Inc.

Tue, Sep 19, 2023 at 07:31 PM

Applied Therapeutics, Inc. (APLT:NASDAQ) jumped higher at $2.53, representing a gain of 27.8%. On Tue, Sep 19, 2023, APLT:NASDAQ touched a New 2-Week High of $2.53. The stock appeared on our News Catalysts scanner on Thu, Sep 07, 2023 at 08:02 PM in the 'BIOTECH' category. From Tue, Sep 05, 2023, the stock recorded 80.00% Up Days and 72.73% Green Days

About Applied Therapeutics, Inc. (APLT:NASDAQ)

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart.

Top 10 Gainers:

Connexa Sports Technologies Inc. (CNXA:NASDAQ), 160.11%
Bird Global Inc. Class A (BRDS:NYSE), 103.59%
Avinger, Inc. (AVGR:NASDAQ), 72.16%
Rackspace Technology Inc. (RXT:NASDAQ), 35.81%
Sezzle Inc. (SEZL:NASDAQ), 34.57%
Elutia Inc Cl A Com (ELUT:NASDAQ), 33.06%
PHAXIAM Therapeutics S.A. (PHXM:NASDAQ), 30.02%
Kaspien Holdings Inc. (KSPN:NASDAQ), 27.84%
Applied Therapeutics, Inc. (APLT:NASDAQ), 27.78%
Orchestra BioMed Holdings Inc Com (OBIO:NASDAQ), 27.61%